DBV Technologies | DBVT - Vermögenswerte





Vermögenswerte Veränderung Datum
Acadia Pharmaceuticals USD 1.74B 137.67M 2026-06
Alnylam Pharmaceuticals USD 7.99B 2.44B 2026-09
Amarin USD 634.08M 9.72M 2026-09
BioCryst Pharmaceuticals USD 557.85M 92.8M 2026-06
BioMarin Pharmaceutical USD 11.72B 3.13B 2026-06
DBV Technologies USD 215.4M 7.8M 2026-09
Galectin Therapeutics USD 27.65M 1.76M 2024-06
Halozyme Therapeutics USD 2.58B 95.31M 2026-06
Incyte USD 7.29B 585.39M 2026-09
Insmed USD 2.23B 123.49M 2026-09
Ionis Pharmaceuticals USD 2.99B 455.5M 2026-06
Neurocrine Biosciences USD 5.36B 452.9M 2026-06
PTC Therapeutics USD 3.21B 42.76M 2026-09
Sarepta Therapeutics USD 3.19B 9.58M 2026-06
Ultragenyx Pharmaceutical USD 1.26B 32M 2026-06
United Therapeutics USD 7.22B 505.9M 2026-06